Non-benzodiazepine Sedation Improves Outcomes in Surgical and Trauma ICUs

Research indicates that non-benzodiazepine sedation significantly improves outcomes for patients in the surgical/trauma intensive care unit (STICU). Traditionally, clinicians utilized benzodiazepines (BZDs) for patients requiring mechanical ventilation. However, data from medical and cardiac ICUs suggest that alternatives like propofol or dexmedetomidine reduce ventilation duration and mortality. This study specifically examined the STICU population to determine if these benefits translate to trauma and surgical patients.

Study Design and Patient Characteristics

The retrospective cohort study included 209 adult patients who required mechanical ventilation for at least 24 hours. Researchers compared those receiving BZD sedation to those receiving non-BZD alternatives. While the BZD group initially presented with higher Charlson Comorbidity Index (CCI) scores, the non-BZD group frequently included patients with traumatic brain injuries. Consequently, the study utilized multivariable modeling to account for these differences in baseline characteristics.

Impact of Non-benzodiazepine Sedation on Clinical Outcomes

The primary finding revealed that patients treated with non-benzodiazepine sedation experienced more days alive and free of mechanical ventilation at 28 days. Statistical analysis showed that non-BZD sedation independently increased the odds of being alive and ventilator-free by nearly seven times compared to BZDs. Furthermore, the researchers observed a significant reduction in the time patients spent in an oversedated state.

The severity of trauma or surgical stress often complicates clinical outcomes in the STICU. Nevertheless, the study suggests that avoiding benzodiazepines may minimize complications such as ventilator-associated pneumonia and delirium. Although the median days alive were similar numerically, the statistical distribution and adjusted odds ratios strongly favored the non-BZD approach. Therefore, clinicians should consider prioritizing non-benzodiazepine agents to optimize recovery for surgical and trauma patients.

Frequently Asked Questions

Why is non-benzodiazepine sedation preferred in the ICU?

Non-benzodiazepine agents like dexmedetomidine or propofol are associated with shorter durations of mechanical ventilation and lower rates of delirium compared to benzodiazepines. They allow for more predictable awakening and better patient cooperation.

Does this study apply to all ICU patients?

While this study focused on the surgical/trauma ICU (STICU), similar benefits have been documented in medical and cardiac ICU populations. It reinforces the general recommendation to limit benzodiazepine use in most critically ill adults.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

VanOtterloo T et al. Effect of Non-benzodiazepine Versus Benzodiazepine Sedation on Days Alive and Free of Mechanical Ventilation in the Surgical/Trauma Intensive Care Unit. Ann Pharmacother. 2026 Apr 06. doi: 10.1177/10600280261433047. PMID: 41937736.

Devlin JW, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825-e873.

Lonardo NW, et al. Propofol and dexmedetomidine-based sedation in the ICU. Pharmacotherapy. 2020;40(12):1210-1221.